Precision Lymphocyte Tuning

ImmVue Therapeutics is pioneering a new era of precision immunotherapy by fine-tuning the immune system’s command centers—ITK in T cells and BTK in B cells—through next-generation allosteric small molecules. While most immuno-oncology approaches aim to unleash the immune system broadly, ImmVue brings surgical precision to immune modulation, restoring immune function where it fails and silencing it where it harms. Our allosteric compounds do not merely block or boost—they reprogram, offering a finely-tuned, safer, and more durable immune response against treatment-resistant cancers and beyond.